Skip to content

Assessment of the diagnostic value of photodynamic fluorescence in the diagnosis of recurrent respiratory papillomatosis

Assessment of the diagnostic value of photodynamic fluorescence in the diagnosis of recurrent respiratory papillomatosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097906
Enrollment
Unknown
Registered
2025-02-27
Start date
2025-03-05
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Respiratory Papillomatosis

Interventions

Gold Standard:Tissue biopsy HPV testing
Index test:Photodynamic Diagnosis

Sponsors

The Affiliated BenQ Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.1-75 years old; 2. Histopathological confirmation of recurrent respiratory papilloma; 3. Patients who choose the treatment regimen as photodynamic therapy 4. Willing to sign the informed consent form

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. History of photosensitizer or photoallergy; 3. Intrapulmonary lesions; 4. Have other throat diseases that affect treatment or follow-up; 5. Severe heart, liver and kidney insufficiency or other contraindications to surgery.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;Positive consistency rate;Negative agreement rate;Area under receiver operating characteristic curve;

Secondary

MeasureTime frame
Maximum photosensitizer uptake in clinical, subclinical and non-pathological areas of papilloma;Differences in anatomical distribution of subclinical lesions;

Countries

China

Contacts

Public ContactYuanyuan Lu

The Affiliated BenQ Hospital of Nanjing Medical University

luyy1234@outlook.com+86 135 1511 6267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026